Skip to main content
Top
Published in: Netherlands Heart Journal 7-8/2012

Open Access 01-08-2012 | ICIN

Idiopathic dilated cardiomyopathy: possible triggers and treatment strategies

Authors: M. Hazebroek, R. Dennert, S. Heymans

Published in: Netherlands Heart Journal | Issue 7-8/2012

Login to get access

Abstract

Despite recent advances in the management of patients with heart failure, morbidity and mortality rates remain high. Common causes of heart failure are ischaemic heart disease, uncontrolled hypertension and valvular disease. However, in up to 50 % of the cases its exact cause remains initially unknown; this condition is called idiopathic dilated cardiomyopathy (DCM). Improved diagnostic methods, most notably the advancements in molecular and immunohistological biopsy techniques and genetic research, have endorsed a new era in the diagnosis and classification of patients with idiopathic DCM. These insights have led to novel aetiology-based treatment strategies and improved outcome. The present article will briefly discuss all causes of DCM with a special focus on inflammatory- and virus-mediated forms of DCM.
Literature
1.
go back to reference Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation. 2000;102:IV-14–23.CrossRef Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation. 2000;102:IV-14–23.CrossRef
2.
go back to reference Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077–84.PubMedCrossRef Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077–84.PubMedCrossRef
3.
4.
5.
go back to reference Lishmanov A, Chockalingam P, Senthilkumar A, et al. Tachycardia-induced cardiomyopathy: evaluation and therapeutic options. Congest Heart Fail. 2010;16:122–6.PubMedCrossRef Lishmanov A, Chockalingam P, Senthilkumar A, et al. Tachycardia-induced cardiomyopathy: evaluation and therapeutic options. Congest Heart Fail. 2010;16:122–6.PubMedCrossRef
8.
go back to reference Dennert R, Velthuis S, Schalla S, et al. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high pvb19 viral load. Antivir Ther. 2010;15:193–201.PubMedCrossRef Dennert R, Velthuis S, Schalla S, et al. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high pvb19 viral load. Antivir Ther. 2010;15:193–201.PubMedCrossRef
9.
go back to reference Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the timic study. Eur Heart J. 2009;30:1995–2002.PubMedCrossRef Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the timic study. Eur Heart J. 2009;30:1995–2002.PubMedCrossRef
10.
go back to reference Staudt A, Schäper F, Stangl V, et al. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation. 2001;103:2681–6.PubMedCrossRef Staudt A, Schäper F, Stangl V, et al. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation. 2001;103:2681–6.PubMedCrossRef
Metadata
Title
Idiopathic dilated cardiomyopathy: possible triggers and treatment strategies
Authors
M. Hazebroek
R. Dennert
S. Heymans
Publication date
01-08-2012
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 7-8/2012
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-012-0285-7

Other articles of this Issue 7-8/2012

Netherlands Heart Journal 7-8/2012 Go to the issue